Platelet Aggregation Devices Market
Platelet Aggregation Devices Market - Global Industry Assessment & Forecast
#
Pages:
154
2022
Feb - 2022
VMR-1293
Segments Covered
By
Product Systems, Reagents, Consumables and Accessories
-
By
Application Clinical Applications, Research Applications
-
By
End User Hospitals, Diagnostic Laboratories, Other End Users
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 532.56 Million |
 Revenue 2030:
|
USD 868.23 Million |
 Revenue CAGR
(2023 - 2030): |
6.30% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Platelet Aggregation Devices Market: By Source, End-User, Application and Region
Market Synopsis:
Global Platelet Aggregation Devices market is valued at USD 532.56 Million in 2022 and is projected to attain a value of USD 868.23 Million by 2030 at a CAGR of 6.30% during the forecast period, 2022–2028. The global market is being fueled by factors such as increased incidences of target diseases, rapid growth in the geriatric population around the world, technological improvements in Platelet Aggregation Devices, and an increasing number of industry-academia collaborations and clinical research. Procedures limits, adverse healthcare changes in the United States, and a scarcity of well-trained and qualified workers are some of the major reasons limiting the market's growth.
Platelet Aggregation Devices Market Size, 2022 To 2030 (USD Million)
AI (GPT) is here !!! Ask questions about Platelet Aggregation Devices Market
The worldwide outbreak of COVID-19 is also likely to benefit the market, and there is significant evidence that SARS-CoV-2 infection is linked to atherothrombotic events. According to the National Clinical Trial Registry (NCT), roughly three clinical trials are now underway to investigate the effect of COVID-19 on Platelet Aggregation Devices, which is predicted to fuel the Platelet Aggregation Devices devices market in the coming years. Platelet Aggregation Devices is used to treat a variety of cardiovascular and bleeding illnesses, but the COVID-19 pandemic is predicted to have an impact on disease treatment as well as the device supply chain around the world.
Increasing Incidences of Cardiovascular Disease
Heart disorders, such as stroke and coronary heart disease, are becoming more common, resulting in a global burden of cardiac mortality, which has fueled the rise of the platelet aggregation devices market. Cardiovascular disease, for example, is mentioned as the underlying cause of mortality in the American Heart Association Research Report 2018, accounting for almost 836,546 deaths in the United States. This equates to approximately one in every three deaths in the country. Every day, around 2,300 Americans die from cardiovascular disease, which equates to one fatality every 38 seconds. The large rise in the number of people suffering from cardiovascular diseases will inevitably raise the use of platelet aggregation devices to study platelet aggregation around the world, and this may push up the price of platelet aggregation devices.
Scarcity of Well-Trained and Qualified Workers
Despite technological advancements and product development over the last decade, the market has been hampered by a shortage of skilled workers who can operate sophisticated instruments like flow cytometers and multi-mode readers. Flow cytometers and spectrophotometers, which are technologically modern and very complicated, produce a wide range of data outputs that require skill to analyze and review. There remains, nevertheless, a global demand-supply gap for trained people.
Market Segmentation:
The Platelet Aggregation Devices Market Is Segmented By Product (Systems, Reagents, Consumables, And Accessories), Application (Clinical Applications And Research Applications), End User (Hospitals, Diagnostic Laboratories, And Other End Users). Based on region, the Platelet Aggregation Devices market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the Platelet Aggregation Devices Market
During the forecast period, North America (especially the United States) is expected to be the fastest expanding region in the worldwide platelet aggregation devices market. Companies involved in the development, manufacture, and distribution of platelet aggregation products are flocking to the North American region. Factors such as an increase in surgical procedures, increased awareness among healthcare professionals (related to the benefits of platelet aggregation testing in disease diagnosis), a large number of patients undergoing cardiovascular surgeries, and an increase in the prevalence of orthopedic, urological, and bleeding disorders are all presenting high-growth opportunities for players in the North American platelet aggregation devices market.
💡 Future-proof Strategies: Anticipate market shifts, adapt to changing customer preferences, and position yourself as an industry leader. Our study equips you with the knowledge to navigate uncertainties with confidence.
Key Players:
Key players operating in the Platelet Aggregation Devices market are: Bio/Data Corporation (US), Helena Laboratories Corporation (US), WerfenLife (Spain),F.Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany).
The Platelet Aggregation Devices market is segmented as follows:
Parameter
Details
Segments Covered
Regions & Countries Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
The Platelet Aggregation Devices market scope can be tabulated as below:
FAQ
Frequently Asked Question
What is the global demand for Platelet Aggregation Devices in terms of revenue?
-
The global Platelet Aggregation Devices valued at USD 532.56 Million in 2022 and is expected to reach USD 868.23 Million in 2030 growing at a CAGR of 6.30%.
Which are the prominent players in the market?
-
The prominent players in the market are Bio/Data Corporation (US), Helena Laboratories Corporation (US), WerfenLife (Spain),F.Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.30% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Platelet Aggregation Devices include
- Increasing Incidences of Cardiovascular Disease
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Platelet Aggregation Devices in 2022.
